Categories: News

Teladoc Health to Announce Second Quarter 2022 Financial Results

PURCHASE, NY, July 12, 2022 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2022 results on Wednesday, July 27, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Conference Call Details

The conference call can be accessed by dialing 1-844-200-6205 for U.S. participants, or 1-929-526-1599 for international participants, and using the access code # 303657; or via a live audio webcast that will be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2021 and #1 among direct-to-consumer telehealth providers in the J.D. Power 2021 U.S. Telehealth Satisfaction Study, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.

Investors:
Patrick Feeley
914-265-7925
IR@teladochealth.com

Staff

Recent Posts

AAMI Foundation Launches Michael Scholla Packaging Engineering Scholarship Fund

Calls for Contributions to Support Future Medical Device & Pharmaceutical Packaging LeadersArlington, Virginia--(Newsfile Corp. -…

21 minutes ago

Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000

Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

1 hour ago

Joe Albe, Ph.D., joins Washington Research Foundation as manager of grants and venture research

Albe brings extensive immunology and translational research experience to his full-time role working with WRF's…

1 hour ago

Omega Healthcare Named a Leader in the 2025-2026 IDC MarketScape for U.S. Revenue Cycle Management Service Solutions

BOCA RATON, Fla., Dec. 10, 2025 /PRNewswire/ -- Omega Healthcare, a leading provider of technology-driven healthcare…

1 hour ago

Homecare Homebase Shares Insights from CMS CY 2026 Home Health Final Rule Updates and Ongoing Advocacy Efforts

Industry collaboration leads to significant improvements in CY 2026 Final Rule but long-term stability remains…

1 hour ago

PatientRightsAdvocate.org Launches Ohio Hospital Price Finder Tool

Ohio patients empowered to compare prices, save on care, fight surprise bills COLUMBUS, Ohio,, Dec. 10,…

1 hour ago